National Bank of Canada FI Raises Holdings in Amedisys, Inc. (NASDAQ:AMED)

National Bank of Canada FI raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 119.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 55,592 shares of the health services provider's stock after buying an additional 30,213 shares during the quarter. National Bank of Canada FI owned about 0.17% of Amedisys worth $5,365,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the business. Alpine Associates Management Inc. boosted its position in Amedisys by 0.9% during the second quarter. Alpine Associates Management Inc. now owns 1,280,897 shares of the health services provider's stock worth $117,586,000 after purchasing an additional 11,000 shares during the period. Westchester Capital Management LLC raised its stake in Amedisys by 9.5% in the third quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock valued at $107,976,000 after purchasing an additional 97,476 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider's stock worth $47,202,000 after buying an additional 19,660 shares during the last quarter. Calamos Advisors LLC lifted its position in shares of Amedisys by 11.6% in the second quarter. Calamos Advisors LLC now owns 397,347 shares of the health services provider's stock valued at $36,476,000 after acquiring an additional 41,220 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in Amedisys by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider's stock worth $33,400,000 after acquiring an additional 9,004 shares during the last quarter. Institutional investors own 94.36% of the company's stock.

Amedisys Trading Up 0.1 %

AMED stock traded up $0.08 during trading on Friday, hitting $85.68. The company had a trading volume of 256,588 shares, compared to its average volume of 371,923. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The company has a 50 day simple moving average of $92.87 and a 200-day simple moving average of $95.02. The firm has a market capitalization of $2.81 billion, a P/E ratio of 33.97, a PEG ratio of 1.84 and a beta of 0.73. Amedisys, Inc. has a 52-week low of $84.06 and a 52-week high of $98.95.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the previous year, the company posted $0.98 EPS. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, research analysts forecast that Amedisys, Inc. will post 4.45 earnings per share for the current fiscal year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.